Lynx1 Capital Management LP Q3 2025 Filing
Filed November 13, 2025
Portfolio Value
$491.3B
Holdings
14
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (14 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 1,534,141 | $144.4B | 29.40% | |
| 2 | STOKSTOKE THERAPEUTICS INC | 5,404,674 | $109.9B | 22.37% | |
| 3 | GHRSGH RESEARCH PLC | 8,601,189 | $104.3B | 21.23% | |
| 4 | PTGXPROTAGONIST THERAPEUTICS INC | 700,014 | $46.5B | 9.47% | |
| 5 | CGEMCULLINAN THERAPEUTICS INC | 5,766,090 | $34.2B | 6.96% | |
| 6 | CCCCC4 THERAPEUTICS INC | 7,098,133 | $15.8B | 3.21% | |
| 7 | TCRXTSCAN THERAPEUTICS INC | 7,857,347 | $14.3B | 2.91% | |
| 8 | DTILPRECISION BIOSCIENCES INC | 1,042,596 | $5.8B | 1.17% | |
| 9 | ADCTADC THERAPEUTICS SA | 1,325,848 | $5.3B | 1.08% | |
| 10 | PASGPASSAGE BIO INC | 623,704 | $5.0B | 1.02% | |
| 11 | DNLIDENALI THERAPEUTICS INC | 261,687 | $3.8B | 0.77% | |
| 12 | IBIOIBIO INC | 1,055,897 | $874.1M | 0.18% | |
| 13 | ALLOALLOGENE THERAPEUTICS INC | 546,119 | $677.2M | 0.14% | |
| 14 | DSGNDESIGN THERAPEUTICS INC | 65,954 | $496.6M | 0.10% |